Q&A: The CEO of the Alzheimer’s Association on the approval of Aduhelm — and why critics should stop dwelling on the decision
(By Andrew Joseph for STAT) Harry Johns is ready to stop talking about whether or not the Food and Drug
Read More(By Andrew Joseph for STAT) Harry Johns is ready to stop talking about whether or not the Food and Drug
Read More(By Elizabeth Cooney for STAT) Their phones are ringing off the hook and their email inboxes are filling up with
Read More(By Juliette Cubanski and Tricia Neuman for Kaiser Family Foundation published June 10, 2021) The question of what would happen when
Read More(By Scott Hensley, Jon Hamilton, and Laurel Wamsley for NPR) The Food and Drug Administration approved the drug aducanumab to
Read MoreHearing the diagnosis of Alzheimer’s disease is difficult to absorb, but once the diagnosis sinks in, it is a good
Read More(By Harris Meyer for Kaiser Health News) The Food and Drug Administration’s decision next week whether to approve the first
Read More(By Judith Graham for Kaiser Health News) The loss of a husband. The death of a sister. Taking in an
Read MoreScientists have found that Alzheimer’s disease has four distinct subtypes based on brain scan images. The researchers’ findings could help
Read More(By Michelle Andrews for Kaiser Health News) After Maria Turner’s minivan was totaled in an accident a dozen years ago,
Read MoreAn estimated 6.2 million Americans age 65 and older are living with Alzheimer’s dementia in 2021. Alzheimer’s disease is a
Read More